Concord Biotech Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Sep '25
    Jun '25
    Mar '25
    Dec '24
    Sep '24
    Total Qtr Revenue cr
    260.41
    217.67
    439.27
    258.95
    320.21
    Other Income Qtr Cr13.3513.689.3814.7310.03
    Operating Revenues Qtr247.06203.99429.88244.22310.18
    Loading chart...
    Operating Expenses Qtr
    158.57
    142.59
    239.46
    146.27
    173.50
    Operating Profit Qtr
    88.49
    61.40
    190.42
    97.95
    136.68
    EBITDA Qtr Cr
    101.84
    75.07
    199.81
    112.68
    146.70
    Depreciation Qtr
    18.39
    17.78
    14.62
    13.26
    13.31
    Net Profit Qtr
    63.58
    44.06
    140.39
    75.92
    95.74
    Basic EPS Qtr
    6.03
    4.21
    13.42
    7.26
    9.15
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -